spacer
home > pmps > autumn 2018 > to connect, or not to connect?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

To Connect, or Not to Connect?

Billions of dollars are wasted each year due to healthcare solutions noncompliance. With the challenges healthcare budgets face (an ageing population and an increasing number of chronic conditions to name a few), how can patients better manage their health? While making a device connected is not a magic bullet to improve compliance and health, they present some clear benefits. How does one decide if a device should be smart, connected, or neither? Clear questions must be asked before deciding if a device should be connected or not. The categories of needs which define this include: engagement, competence, onboarding, re-onboarding, and more. These should be identified by exploring both connected and non-connected solutions, after which, the solutions to whether a product is connected or not becomes clearer.

In the regulated world of healthcare, the true cost of a connected solution is high and not just financially. Patient attitudes around sharing their health data must be considered, and the benefits they receive should be worthwhile for providing that information.

Understanding the Problem

Many stakeholders are involved in delivering and managing a patient’s therapy. These range from the patient, the caregivers, and healthcare professionals who deliver the care, through to the pharmacist who dispenses the therapy, the payer who funds it, and, not forgetting, the pharmaceutical company that developed it. Each of these stakeholders has different needs and desires, which may or may not be satisfied through the use of a connected medical device. For example, a pharma company may want to ensure that their clinical trials run smoothly so that the therapy is successful, effective, and meets the needs of the regulators. Healthcare professionals want better clinical outcomes for patients, and, ultimately, the patient wants to have their therapy funded and to be able to manage their condition successfully.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Charlotte Harris is a Senior Consultant at Team Consulting whose work typically focusses on managing the strategic and creative ‘front-end’ of the product development process. She has over 20 years’ experience in the medical device industry and has worked in clinical, start-up, and consultancy environments. Charlotte studied medical engineering and has a BEng from Cardiff University, UK, and an MSc from Kings College London, UK.

Tom Etheridge is an Industrial Design Consultant at Team Consulting who uses his experience to deliver holistic support to design, engineering, and human factors groups. He has a degree in industrial design technology from Brunel University, UK, and has worked in a design consultancy environment since graduating in 2010. Tom has been the lead industrial designer on several projects ranging from medical devices to consumer electronics.

Paul Greenhalgh heads Team Consulting’s design group. He is a passionate advocate of the importance of ‘good design’ and is involved in all stages of product development, from front-end innovation to detailed design for manufacture.
spacer
Charlotte Harris
spacer
spacer
spacer
Tom Etheridge
spacer
spacer
spacer
Paul Greenhalgh
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement